Statement of Changes in Beneficial Ownership (4)

FORM 4 [ X ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Lyle David	2. Issuer Name and Ticker or Trading Symbol ENTROPIC COMMUNICATIONS INC [ ENTR ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                      _____ 10% Owner __ X __ Officer (give title below)      _____ Other (specify below) Chief Financial Officer
(Last)          (First)          (Middle) 6290 SEQUENCE DRIVE	3. Date of Earliest Transaction (MM/DD/YYYY) 4/30/2015
(Street) SAN DIEGO, CA 92121 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	4/30/2015		D		48893.0	D	(1)	0	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$1.99	4/30/2015		D			59823.0	(2)	3/19/2018	Common Stock	59823	(2)	0	D
Non-Qualified Stock Option (right to buy)	$2.41	4/30/2015		D			100000.0	(3)	5/21/2019	Common Stock	100000	(3)	0	D
Non-Qualified Stock Option (right to buy)	$3.86	4/30/2015		D			90000.0	(4)	4/11/2024	Common Stock	90000	(4)	0	D
Non-Qualified Stock Option (right to buy)	$4.11	4/30/2015		D			78000.0	(5)	4/12/2023	Common Stock	78000	(5)	0	D
Non-Qualified Stock Option (right to buy)	$4.86	4/30/2015		D			200000.0	(6)	4/8/2020	Common Stock	200000	(6)	0	D
Non-Qualified Stock Option (right to buy)	$5.1	4/30/2015		D			69000.0	(7)	4/13/2022	Common Stock	69000	(7)	0	D
Non-Qualified Stock Option (right to buy)	$7.45	4/30/2015		D			105000.0	(8)	4/13/2021	Common Stock	105000	(8)	0	D
Restricted Stock Unit	(9)	4/30/2015		D			158700.0	(9)	(9)	Common Stock	158700	(9)	0	D

Explanation of Responses:
( 1)	Disposed of pursuant to the Agreement and Plan of Merger and Reorganization dated as of February 3, 2015 (the Merger Agreement, and the transactions contemplated therein, the Merger), by and among the Issuer, MaxLinear, Inc. (MaxLinear), Excalibur Acquisition Corporation and Excalibur Subsidiary, LLC, whereby each share of Issuer common stock was canceled in exchange for a cash payment of $1.20 per share and .2200 of a share of MaxLinear Class A Common Stock, with fractional shares being paid in cash. The market value of MaxLinear Class A Common Stock received under the Merger Agreement was $8.53 per share on the effective date of the Merger.
( 2)	The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 21,430 shares of MaxLinear Class A Common Stock with an exercise price of $5.56 per share.
( 3)	The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 35,822 shares of MaxLinear Class A Common Stock with an exercise price of $6.73 per share.
( 4)	1/4th of the shares vest one year after the Vesting Commencement Date beginning 4/11/14. 1/48th of the shares vest monthly thereafter over the next three years. The option was assumed by MaxLinear in the Merger and replaced with an option to purchase 32,240 shares of MaxLinear Class A Common Stock with an exercise price of $10.78 per share.
( 5)	1/4th of the shares vested one year after the Vesting Commencement Date beginning 4/12/13. 1/48th of the shares vest monthly thereafter over the next three years. The option was assumed by MaxLinear in the Merger and replaced with an option to purchase 27,941 shares of MaxLinear Class A Common Stock with an exercise price of $11.48 per share.
( 6)	The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 71,645 shares of MaxLinear Class A Common Stock with an exercise price of $13.57 per share.
( 7)	1/4th of the shares vested one year after the Vesting Commencement Date beginning 4/13/12. 1/48th of the shares vest monthly thereafter over the next three years. The option was assumed by MaxLinear in the Merger and replaced with an option to purchase 24,717 shares of MaxLinear Class A Common Stock with an exercise price of $14.24 per share.
( 8)	The option which vested over a four year period from the date of grant and is fully-vested and exercisable, was assumed by MaxLinear in the Merger and replaced with an option to purchase 37,613 shares of MaxLinear Class A Common Stock with an exercise price of $20.80 per share.
( 9)	The RSU represents a contingent right to receive Issuer common stock on a one-for-one basis. The RSU, which vests in equal annual installments, was assumed by MaxLinear in the Merger and converted into restricted stock units representing a contingent right to receive an aggregate of 56,850 shares of the Class A Common Stock of MaxLinear on the same terms and conditions (including with respect to vesting and exercisability) as were applicable to the RSU prior to the consummation of the Merger.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Lyle David 6290 SEQUENCE DRIVE SAN DIEGO, CA 92121			Chief Financial Officer

Signatures
By: Lance W. Bridges, as attorney-in-fact For: David B. Lyle		5/4/2015
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.